Please assess the completion status of the following clinical trial:

Trial Title: Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults Receiving Seasonal Influenza Vaccine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Written informed consent~* Adults 20-59 years of age~Exclusion Criteria:~* Allergies to eggs, thimerosal, gentamicin sulphate, neomycin~* Life-threatening reaction to previous Flu vaccine~* Bleeding disorder~* Pregnancy~* Receipt of blood or blood products in past 3 months~* Chronic illness~* Compromised immune system~* Previous lab-confirmed H1N12009 infection~* Receipt of H1N12009 vaccine~* Receipt of Seasonal Influenza vaccine since March 2009

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 59 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: OTHER): Group A: One dose of the licensed H1N1 vaccine and one dose of the seasonal influenza vaccine given concurrently
- 2 (Type: OTHER): Group B: One dose of seasonal influenza vaccine given 3 weeks after administration of one dose of the licensed H1N1 vaccine

Based on this trial design, predict the completion outcome and termination type (if applicable).